Bio Europe 2023 in Munich was a huge success for Biotts. It presented us with the opportunity to showcase our technology platform and exciting projects that are pushing the limits of transdermal drug delivery to the entire industry, and follow up individually to initiate new collaborations. It also enabled us to connect efficiently with key partners for the clinical trials for our transdermal semaglutide program that are set to start in the New Year.
Explore our comprehensive presentation, conveniently accessible both in the carousel below and as a downloadable PDF.
